Bank of America
AVBP icon

Bank of America’s ArriVent BioPharma AVBP Stock Holding History

Bank of America’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
80,208
+23,687
+42% +$535K ﹤0.01% 4168
2025
Q4 		$1.14M Buy
56,521
+10,544
+23% +$219K ﹤0.01% 4446
2025
Q3 		$848K Buy
45,977
+15,230
+50% +$299K ﹤0.01% 5435
2025
Q2 		$669K Buy
30,747
+1,462
+5% +$30.4K ﹤0.01% 5549
2025
Q1 		$541K Sell
29,285
-16,259
-36% -$398K ﹤0.01% 5604
2024
Q4 		$1.21M Buy
45,544
+2,279
+5% +$65.4K ﹤0.01% 4861
2024
Q3 		$1.02M Buy
43,265
+36,964
+587% +$839K ﹤0.01% 5049
2024
Q2 		$117K Buy
6,301
+4,042
+179% +$72.1K ﹤0.01% 6186
2024
Q1 		$40.3K Buy
+2,259
New +$45.6K ﹤0.01% 6582

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's AVBP Position: Q1 2026 in Review

Bank of America increased its ArriVent BioPharma (AVBP) stake by 42% in Q1 2026, buying an estimated $535K and bringing the position to 80,208 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #4168.

Bank of America first reported a position in AVBP in Q1 2024 and has held it in 9 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Bank of America held 80,208 shares of ArriVent BioPharma worth $1.85M as of Q1 2026.
  • Bank of America bought 23,687 ArriVent BioPharma shares in Q1 2026, an estimated $535K.
  • ArriVent BioPharma made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4168 holding.
  • Bank of America first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 9 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.